SAN JOSE, Calif., July 11 /PRNewswire-FirstCall/ -- VNUS(R) Medical
Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for
the minimally invasive treatment of venous reflux disease, announced today the
resignation of Kathleen D. LaPorte from the Board of Directors. Ms. LaPorte
has served on VNUS' Board of Directors since April 1997 and was a general
partner in a venture capital firm that funded the company during its start-up
activities. There are no immediate plans for a replacement Director.
"The Board and management of VNUS would like to sincerely thank Kathy for
her many contributions, support, and sound advice as a key member of the Board
since the company's early days," said Brian Farley, President and CEO. "As one
of the earliest venture capital investors, Kathy's departure from the Board is
a normal step in the company's corporate governance since its IPO in October
2004. We expect to continue our past practice of looking to replace venture
investors with highly qualified medical device industry experts."
ABOUT VNUS MEDICAL TECHNOLOGIES, INC.
Founded in 1995 and headquartered in San Jose, California, VNUS Medical
Technologies is a worldwide leader in medical devices for the minimally
invasive treatment of venous reflux disease, a progressive condition that
causes the varicose veins afflicting 25 million Americans. The pioneering
company in the field, VNUS offers the ClosureFAST system, which consists of a
proprietary radiofrequency (RF) generator and proprietary disposable
endovenous catheters and devices to close diseased veins through the
application of temperature-controlled RF energy. VNUS devices have been used
in more than 300,000 procedures worldwide. For more information, visit
http://www.vnus.com/.
FORWARD-LOOKING STATEMENTS
VNUS has made forward-looking statements in this press release within the
meaning of Section 21E of the Securities Exchange Act of 1934, as amended.
These statements related to Board membership are based on information
available to VNUS as of the date of this press release and are based on
information available to the company as of the date hereof. VNUS expressly
disclaims any intent or obligation to update these forward-looking statements
except as required by law.
SOURCE VNUS Medical Technologies, Inc.